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a b s t r a c t
Background and purpose: Involuntary expression of socially unacceptable words (coprolalia)
or gestures (copropraxia) is the best-known symptom of Gilles de Tourette syndrome (GTS)
that contributes to the social impairment. The aim of the study was to assess the prevalence,
age at onset and co-occurring symptoms of coprophenomena.
Materials and methods: One hundred and sixty-eight consecutive subjects with GTS including
94 adults and 74 children and aged between 4 and 54 years (mean: 18.0  8.3) were studied.
Demographic and clinical data were obtained from medical history and neurological exami-
nation.
Results: Coprolalia or copropraxia appeared in 44 patients. Both coprophenomena were
present in 9 patients. Coprolalia occurred in 25.0% (n = 42) and copropraxia in 6.5% (n = 11) of
patients. Mean age at onset was 12.2  5.7 years (range: 4–33) for coprolalia and 12.4  4.9
years (range: 7–24) for copropraxia. Coprolalia started 4.4  3.7 years (range: 0–16) after the
onset of disease; copropraxia started 6.1  4.0 years (range: 1–12) after the onset of the
disease. Coprolalia began in adulthood in six patients only, and copropraxia in one person. In
six patients, coprolalia appeared in the ﬁrst year of the disease. Copropraxia was never seen
in the ﬁrst year of the disease. Coprophenomena were more frequent in patients with
comorbid mental disorders, behavioral problems and severe tics. Three quarters of patients
reported signiﬁcant inﬂuence of coprophenomena on daily living.
Conclusions: Coprophenomena affect one quarter of GTS patients, appear in the time when
tics are most severe, and are positively associated with comorbidity and more severe form of
disease. Coprophenomena may reﬂect more widespread dysfunction of brain in GTS.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Gilles de la Tourette syndrome (GTS) is a movement disorder
characterized by multiple motor and at least one vocal tic* Corresponding author at: Katedra i Klinika Neurologii, SP CSK WUM,
E-mail address: piotr.janik@wum.edu.pl (P. Janik).
0028-3843/$ – see front matter # 2014 Polish Neurological Society. Pu
http://dx.doi.org/10.1016/j.pjnns.2013.03.001which have been present for more than a year with the age at
onset under 18 years [1]. This childhood-onset movement
disorder is commonly associated with mental and behavioral
comorbidities. GTS is not uncommon, with the prevalence rate
about 1% all over the world in children aged 5–18 years [2]. Banacha 1a, 02-097 Warszawa, Poland.
blished by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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and copropraxia, complex motor tic. Coprolalia is deﬁned as an
involuntary utterance of obscene words or socially inappro-
priate and derogatory remarks. It is usually expressed out of
social or emotional context and may be spoken in a louder tone
or different cadence than normal conversation. Copropraxia is
involuntarily performing obscene gestures often having a
vulgar and insulting content. The prevalence rates vary from
8.5% to 50% for coprolalia [3,4] and from 5.7% to 25% for
copropraxia among patients with GTS [5–7]. Coprophenomena
are not unique to tic disorders. They may occur after stroke,
encephalitis, in other neurological conditions such as chor-
eoacanthocytosis, epilepsy, frontotemporal dementia, obses-
sive–compulsive disorder without tics, and Lesch–Nyhan
syndrome [8–10].
Although coprolalia and copropraxia are two of the most
spectacular features of GTS, the research on coprophenomena
in Polish patients with GTS is very limited. The present study is
an attempt to identify the prevalence of both tics, their typical
appearance in relation to tic onset, course into adult life and
associations with comorbid mental disorders, behavioral
symptoms and tic severity in Polish GTS cohort.
2. Materials and methods
A total of 168 consecutively examined patients with GTS were
included into the study. All the subjects were personally
interviewed by the author of the study (PJ) using a short
questionnaire on demographic and clinical data. Diagnosis of
GTS was made according to DSM-IV-TR criteria [1]. Diagnosis
of mental disorders was established retrospectively accord-
ing to earlier psychiatric examinations or at the time of
examination according to DSM-IV criteria. Clinical data
regarding coprolalia, copropraxia and behavioral problems
were collected retrospectively at the time of examination. The
study was designed as a one-time registration study and no
new clinical data obtained on follow-up visits were included
into analysis.
The number of mental disorders was calculated for each
patient by assigning the value 1 to each existing disorder and
adding the values together. Mean value was counted by
dividing the sum of all comorbidities by the number of
patients. Obsessive–compulsive behavior (OCB) was diagnosed
if obsessive thoughts and activities did not signiﬁcantly
inﬂuence daily activity and lasted less than an hour per day.
In contrast to mental disorders, behavioral problems did not
have strictly established criteria of diagnosis according to
available psychiatric classiﬁcations. The illness was identiﬁed
on the grounds of patient's behavior and author's experience.
Behavioral problem was diagnosed if the condition had a
signiﬁcant impact on patient's daily life activities. Behavioral
problems included: anger control problems, sleep problems,
sexually inappropriate behavior, self-injurious behavior, sig-
niﬁcant social skills problems. Anger control problems were
deﬁned as uncontrolled bursts of anger and aggression which
appeared suddenly of minimal provocation, and manifested as
physical or verbal aggression against other people. These
symptoms result from the inability to tolerate minor frustra-
tion and delay of gratiﬁcation. Sleep problems and sexuallyinappropriate behavior were diagnosed when the symptoms
did not meet the criteria of severe disorders according to
DSM-IV. Examples of sexually inappropriate behavior are:
touching other people's genitals (parents, family members,
strangers), frequent and overt masturbation, constant talking
about matters concerning sex and forcing other people to
listen. Social skills problems are difﬁculties in establishing and
maintaining contacts with other people, lack of friends, wrong
interpretation of others' cues and intensions, excessive
suspiciousness toward other people and tendency to blame
other people for one's failures. Self-injurious behavior includ-
ed self-cutting, head banging, self-hitting, biting (cheeks, nails,
lips), scar-scratching, etc. The presence of one self-injurious
behavior enabled the diagnosis. The total and mean value of
behavioral symptoms was counted the same way as in case of
mental disorders.
The intensity of tics was deﬁned as the maximal intensity
ever experienced by the patient (not necessarily at the
moment of examination). Thus, tics were determined retro-
spectively on the basis of a medical history. This deﬁnition
prevented the disease from, e.g. being classiﬁed as mild in
adults with mild tics at the moment of evaluation but with a
history of severe tics during childhood. The intensity of tics
was deﬁned descriptively. Tics were divided into mild,
moderate and severe. Mild tics were deﬁned if they were
not related to physical or mental discomfort, problems in
relations with peers, less than expected academic achieve-
ments and the need to treat. Moderate tics generated only
small and temporary restrictions in patients' daily life (e.g.
few-day absence from school, difﬁculties with homework).
Severe tics caused the inability to continue normal daily
activities (e.g. repeating grades, losing work), a physical
discomfort (e.g. neck pain caused by cervical tics), a signiﬁcant
deterioration of quality of life and a necessity of neuroleptic
therapy.
The negative impact of coprophenomena on daily living
was marked if the patient reported subjective and signiﬁcant
social impairment with regard to the family, himself/herself
and school or work. No quantitative scales were used.
For the purpose of the study, certain groups had been
distinguished. Those patients with coprophenomena were
termed K+, whereas those without coprolalia and copropraxia
as K. Likewise, those patients having tics without mental
disorders as the clinical manifestation of the disease were
termed GTS and those with comorbid mental disorders as
GTS+.
Although GTS is a developmental disorder of childhood
onset, adult persons prevailed among subjects were included
into the study. Demographic data of children, adults and all
GTS patients were presented in Table 1. Children were deﬁned
as age 17 years.
3. Statistical analysis
Obtained data were statistically analyzed with Excel and
Statistica 8.0 software. Quantitative data were shown as the
mean  standard deviation and evaluated using the Mann–
Whitney U-test. Qualitative data were compared using the
x2 test. Signiﬁcance level was set at p = 0.05.
Table 1 – Demographic data of children, adults and all Gilles de la Tourette syndrome (GTS) patients included into the study.
Characteristics Children (n = 74) Adults (n = 94) All GTS patients (n = 168)
Age at evaluation [years]
Mean  SD (range) 12.1  3.3 (3.8–17.9) 25.4  6.6 (18.1–53.7) 18.0  8.3 (3.8–53.7)
Disease duration [years]
Mean  SD (range) 5.4  3.1 (1–13.2) 16.6  6.8 (1–43.7) 10.2  7.4 (1–43.7)
Gender
Males/females (n) 86/8 59/15 145/23
Age at tic onset [years]
Mean  SD (range) 6.7  3.1 (2–16) 8.2  3.6 (3–18) 7.3  3.4 (2–18)
Intensity of tics
Severe 13.5% (n = 10) 22.3% (n = 21) 18.5% (n = 31)
Moderate 56.8% (n = 42) 61.7% (n = 58) 59.5% (n = 100)
Mild 29.7% (n = 22) 16.0% (n = 15) 22.0% (n = 37)
SD – standard deviation.
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Coprolalia occurred in 25.0% (42/168) and copropraxia in 6.5%
(11/168) of patients. Both coprophenomena were present in
nine patients. At least one of two coprophenomena (coprolalia
or copropraxia) was present in 44 patients.
Age at onset of coprolalia and copropraxia was not known
in two and one patient, respectively. Mean age at onset was
12.2  5.7 years (range: 4–33) for coprolalia and 12.4  4.9 years
(range: 7–24) for copropraxia. The age at the onset of
coprophenomena is presented in Fig. 1. Coprolalia started
4.4  3.7 years (range: 0–16) and copropraxia appeared 6.1  4.0
years (range: 1–12) after the tic onset. Only in 15% (6/40) of
patients, coprolalia was the early symptom of GTS which
means that it appeared in the ﬁrst year of the disease.
Copropraxia was never seen at that stage of GTS. Majority of
patients developed coprolalia (85%, 34/40) and copropraxia
(90%, 9/10) before the age of 18.
Comorbid mental disorders occurred in 75% (126/168) of
patients (GTS+ group); GTS group consisted of 25% (42/168)
of cases. Coprophenomena occurred considerably more often
in GTS+ group compared to GTS group and were associated
with more frequent appearance of mental disorders and
behavioral problems (Table 2). Tics rated as severe wereFig. 1 – The age at the onset of coprophenomena in patients
with Gilles de la Tourette syndrome.reported more frequently in K+ group but the difference
reached only borderline statistical signiﬁcance ( p = 0.068).
Characteristics that differed K+ and K groups were shown in
Table 2. K+ and K groups did not differ with regard to sex:
79.5% (35/44) vs. 88.7% (110/124) of males, respectively
( p = 0.1287). We analyzed also data reported by children and
adults separately. These ﬁndings are shown in Table 3. Positive
family history did not differentiate K+ and K groups
( p = 0.42).
Coprolalia was continuing in 61.9% (26/42) of patients at the
time of evaluation, and copropraxia in 81.8% (9/11). In the
remaining patients, coprolalia (n = 16) and copropraxia (n = 2)
disappeared entirely before the clinical evaluation. Duration of
discontinuous and persistent coprolalia did not differ (3.4
 4.8, range: 0–18 vs. 4.2  5.0, range: 0–21 years; p = 0.4332).
Duration of discontinuous and persistent copropraxia was
similar as well (1.25  1.1, range: 0.5–2.0 vs. 1.9  3.2, range: 0–8
years; p = 0.4862).
The course of coprolalia and copropraxia did not change
over time in more than half of the patients (57.1%, 24/42 and
63.6%, 7/11, respectively). Minority of patients developed
intermittent (come-go-come again) or self-limited (come and
go) course of coprophenomena.
The information about the treatment was not available
from one patient with coprolalia, and one person with both
coprophenomena and six cases without coprophenomena.
Eighty-one percent of patients (34/42) in K+ group, and 68.6%
(81/118) cases in K group were ever treated with tic reducing
medications ( p = 0.13). The mean number of all tic-reducing
medications ( p = 0.22), dopamine receptor blocking drugs
( p = 0.82), benzodiazepines ( p = 0.06) and clonidine ( p = 0.47)
used in K+ patients was similar compared to K group. All tic-
reducing medications were analyzed retrospectively, includ-
ing drugs used before the onset of coprophenomena and after
coprophenomena had ceased. All used tic-reducing medica-
tions in GTS patients are listed in Table 4.
Seventy-ﬁve percent of all patients with coprophenomena
(n = 44) reported signiﬁcant inﬂuence of coprolalia and
copropraxia on daily living. These tics affected the family
(25/44), the patient himself/herself (17/44), school or work
(15/44). Only a quarter of patients reported coprophenomena
as being not troublesome in their lives.
Table 2 – Characteristics of Gilles de la Tourette syndrome (GTS) patients with and without coprophenomena.a
Patients with GTS (n = 168)
Patients with
coprophenomena (n = 44)
Patients without
coprophenomena (n = 124)
P-value
GTS without mental disorders (n = 42) 13.6% (6) 29.0% (36)
GTS with mental disorders (n = 126) 86.4% (38) 70.1% (88) 0.0434
Mental disorders
ADHD 54.5% (24) 35.5% (44) 0.0269
OCD/OCB 61.4% (27) 36.3% (45) 0.0039
Learning disorders 40.9% (18) 25.8% (32) 0.0598
Anxiety disorders 38.6% (17) 13.7% (17) 0.0004
Mood disorders 20.4% (9) 9.7% (12) 0.0641
Conduct disorder 20.4% (9) 4.0% (5) 0.0007
Enuresis 15.9% (7) 9.7% (12) 0.2636
Stuttering 9.1% (4) 10.5% (13) 0.9780
Trichotillomania 6.8% (3) 0% (0) 0.0231
Behavioral problems
Anger control problems 52.3% (23) 16.1% (20) 0
Sleep problems 50.0% (22) 21.8% (27) 0.0004
Self-injurious behavior 38.6% (17) 8.9% (11) 0.00001
Sexually inappropriate behavior 18.2% (8) 4.8% (6) 0.0061
Social skills problems 29.5% (13) 4.0% (5) 0
Mean number  SD of
Mental disorders 2.7  1.9 1.5  1.3 0.0001
Behavioral problems 1.9  1.4 0.6  0.9 0
Intensity of tics
Severe 31.8% (14) 18.6% (23) 0.0680
Moderate 56.8% (25) 60.5% (75) 0.6704
Mild 11.4% (5) 21.0% (26) 0.1595
ADHD – attention deﬁcit with hyperactivity disorder; OCD/OCB – obsessive-compulsive disorder/obsessive-compulsive behavior; SD – standard
deviation.
a Data shown as percentages (numbers) unless otherwise stated.
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The frequency of coprophenomena in Polish population with
GTS was 25% for coprolalia and 6.5% for copropraxia. Our data
are consistent with other studies, ﬁnding that most people
with GTS never display these tics. Frequencies reported by
other authors are quite variable: 8–50% for coprolalia [11,4] and
3–25% for copropraxia [6,7,12]. It is considered that their
prevalence is much lower in non-selected samples. The rate of
coprophenomena is higher in selected samples which consist
of the patients who are referred to psychiatrist due to their
mental disorders, neurologist due to predominant tics or
pediatrician because they are children. Our ﬁndings are in the
middle of the range for coprolalia and on the low side of range
for copropraxia. Coprolalia in Polish cases is nearly four times
as common as copropraxia that is the highest ratio compared
to literature (range 1.12–3.23) [5,6].
Copropraxia is highly socially unacceptable symptom and
some adult patients may not admit its presence. Coprolalia
was much more likely than copropraxia to occur as the
exclusive expression of coprophenomena. 'Isolated' copro-
praxia appeared very rarely.
Our results suggest that coprophenomena appear usually
around the age of 12. This ﬁnding is consistent with other
studies. The mean age at onset of coprolalia in our GTS samplewas within the range of 8–15 years reported by other authors
[5,11,13–16]. However, one-third of Polish patients developed
coprophenomena in early childhood or late adulthood. We
found that coprolalia could start as late as 33, and copropraxia
– 24 years of age. Fifteen percent of patients developed
coprolalia after the age of 18, and in another 15% coprolalia
was present at time of tic onset. Copropraxia started in
adulthood in 10% of patients and was never present at the
beginning of the disease. Freeman et al. [5] in large multicenter
study found that 1/10 of patients may developed coprolalia at
the time of tic onset and in adult age as well, which is similar to
our ﬁndings. However, they also found that copropraxia may
be the initial sign of the disease that we did not see in Polish
patients. The reason for that is probably small number of
copropraxia cases in our series. In Polish patients, the delay
between tic and coprophenomena onset was 4 years and 5
months for coprolalia and 6 years and 1 month for copropraxia.
This ﬁnding is within the range of other studies (2.2–8.1 years)
[5,11,13,15].
We conﬁrm the results of other studies that copropheno-
mena appear in time when tics are at their peak severity. Tics
tend to be most severe during the preadolescent period,
between 10 and 12 years of age, and in most cases diminish
during adolescence and adulthood [17,18]. We believe that tic
severity is related to the presence of coprophenomena that
force the patients to seek medical counseling. Four-ﬁfths of
Table 3 – Characteristics of children and adult Gilles de la Tourette syndrome (GTS) patients with and without
coprophenomena.
GTS patients group
Children (n = 71) Adults (n = 97)
Patients with
coprophenomena
(n = 21)
Patients without
coprophenomena
(n = 50)
P-value Patients with
coprophenomena
(n = 23)
Patients without
coprophenomena
(n = 74)
P-value
GTS without mental disorders 14.3% (3) 34.0% (18) 0.0910 13.0% (3) 25.7% (20) 0.3278
GTS with mental disorders 85.7% (18) 66.0% (33) 87.0% (20) 74.3% (55)
Mental disorders
ADHD 52.4% (11) 40.0% (20) 0.3371 56.5% (13) 32.4% (24) 0.0378
OCD/OCB 57.1% (12) 24.0% (12) 0.0071 65.2% (15) 44.6% (33) 0.0840
Learning disorders 38.1% (8) 28.0% (14) 0.4045 43.5% (10) 24.3% (18) 0.0766
Anxiety disorders 38.1% (8) 6.0% (3) 0.0023 39.1% (9) 18.9% (14) 0.0477
Mood disorders 9.5% (2) 2.0% (1) 0.4284 30.4% (7) 14.9% (11) 0.0951
Conduct disorder 14.3% (3) 2.0% (1) 0.1375 26.1% (6) 5.4% (4) 0.0140
Enuresis 14.3% (3) 12.0% (6) 0.8993 17.4% (4) 8.11% (6) 0.3755
Stuttering 9.5% (2) 6.0% (3) 0.9829 8.7% (2) 13.5% (10) 0.8023
Trichotillomania 0% (0) 0% (0) 13.0% (3) 0% (0) 0.0136
Behavioral problems
Anger control problems 47.6% (10) 8.0% (4) 0.0005 56.5% (13) 21.6% (16) 0.0014
Sleep problems 42.9% (9) 18.0% (9) 0.0291 56.5% (13) 24.3% (18) 0.0038
Self-injurious behavior 71.4% (6) 94.0% (3) 0.0265 47.8% (11) 10.8% (8) 0.0003
Sexually inappropriate behavior 28.8% (6) 2.0% (1) 0.0028 8.7% (2) 6.8% (5) 0.8828
Social skills problems 33.3% (7) 4.0% (2) 0.0027 26.1% (6) 4.1% (3) 0.0056
Mean number  SD of
Mental disorders 2.3  1.8 1.2  1.1 0.0080 3.0  2.0 1.6  1.4 0.0033
Behavioral problems 1.8  1.5 0.4  0.8 0.0002 2.0  1.22 0.7  0.9 0.0000
Intensity of tics
Severe 23.8% (8) 10.0% (14) 0.24896 39.1% (9) 24.3% (18) 0.1664
Moderate 61.9% (12) 60.0% (12) 0.8809 52.2% (12) 60.8% (45) 0.4623
Mild 14.3% (11) 30.0% (20) 0.2756 8.7% (2) 14.9% (11) 0.6831
ADHD – attention deﬁcit with hyperactivity disorder; OCD/OCB – obsessive–compulsive disorder/obsessive–compulsive behavior; SD – standard
deviation
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treatment, three quarters of them found these tics severely
affecting their lives and two-thirds of cases had at least one of
coprophenomena at the time of evaluation.
What is of special interest in our study is that course of
coprophenomena may be unusual and different from typical
course of tics. In most patients, severity of tics usually changes
over time with waxing and waning pattern. In more than half of
our patients, coprophenomena, that are kind of complex tics,
were persistent and invariable over time, with the mean
duration time of 4 years for coprolalia and 2 years for
copropraxia which is rather unusual for tics. This may result
from excessive proportion of adult persons in our series (56%) in
whom tics tend to stabilize. However, our ﬁnding is very similar
to that reported by Freeman et al. [5] who included into the study
mainly children (85%). It cannot be excluded that persistent
coprophenomena may eventually cease but long duration, 21
years for coprolalia and 8 years for copropraxia in two extreme
cases, suggest that in substantial proportion of patients these
tics will have invariable course. On the other hand, nearly all
patients with coprophenomena were treated with tic-reducing
medications and the agents may have suppressed these tics to
decrease the number of persistent coprophenomena. In the
remaining patients, nearly less than half of the total population,coprophenomena had a typical course for tics that changed over
time. In these cases coprophenomena remitted, resumed,
ceased or had intermittent course.
Tics rated as severe were found more often in patients with
coprophenomena at borderline signiﬁcance. However, tic-
reducing medications in patients without coprophenomena
were used as frequently as in K+ group during all disorder.
Haloperidol, thioridazine and risperidone were three most
popular medications in both K+ and K groups (Table 4).
Sulpiride and clonazepam were even more frequently used in
patients without coprophenomena. These results conﬁrm our
previous ﬁndings that there is a tendency to treat the patients
even with mild, not troublesome tics in our country [19].
We have found a very clear association of coprophenomena
with comorbidity and, to a lesser degree, tic severity. The
prevalence of mental disorders, behavioral symptoms and
severe intensity of tics in patients with GTS was higher if
coprophenomena occurred. The incidence of copropheno-
mena among GTS group was very low. Although it is not
known whether coprophenomena are the risk factor for some
psychiatric disorders or rather inversely, the presence of
coprophenomena contributes to more complex and more
severe clinical phenotype of GTS. Additionally, there is some
evidence from functional neuroanatomy studies that complex
Table 4 – Tic-reducing medications used in patients with
and without coprophenomena (n – number of patients
treated with particular medication; N – number of all
treated patients in patients with or without copropheno-
mena; % – calculated as n:N T 100%).
Patients with
coprophenomena
(N = 34)
Patients without
coprophenomena
(N = 79)
Neuroleptics
Haloperidol 70.6% (24) 65.8% (52)
Thioridazine 20.6% (7) 26.6% (21)
Risperidone 32.4% (11) 27.9% (22)
Sulpiride 5.9% (2) 12.7% (10)
Pimozide 5.9% (2) 3.8% (3)
Tiapride 5.9% (2) 5.1% (4)
Chlorprothixene 0% (0) 1.3% (1)
Olanzapine 5.9% (2) 2.5% (2)
Perazine 2.9% (1) 0% (0)
Zuclopenthixol 0% (0) 2.5% (2)
Quetiapine 2.9% (1) 2.5% (2)
Chlorpromazine 0% (0) 1.3% (1)
Perfenazine 0% (0) 2.5% (2)
Triﬂuoperazine 0% (0) 1.3% (1)
Benzodiazepines
Clonazepam 2.9% (1) 15.2% (12)
Clorazepate 2.9% (1) 2.5% (2)
Diazepam 2.9% (1) 3.8% (3)
Lorazepam 0% (0) 1.3% (1)
Bromazepam 0% (0) 2.5% (2)
Other medications
Clonidine 14.7% (5) 22.8% (18)
Diltiazem 2.9% (1) 1.3% (1)
Botulinum toxin 0% (0) 1.3% (1)
Baclofen 0% (0) 1.3% (1)
Pergolide 0% (0) 1.3% (1)
Ropinirole 0% (0) 1.3% (1)
Topiramate 0% (0) 2.5% (2)
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studies using positron emission tomography and functional
magnetic resonance showed that complex tics, including
coprolalia, involve widespread changes of activity in basal
ganglia and cerebral cortex [20,21]. Thus, if coprophenomena
are associated with more severe clinical phenotype and
widespread changes of neural activity, their presence is
probably related to more pronounced dysfunction of brain
in GTS.
We are aware of important limitations of our study. There
was substantial amount of adults included into the study. Data
obtained from these patients were retrospective with the
possibility of recall bias. This may be due to patients'
forgetfulness or natural course of some diseases, e.g. tic severity
and attention deﬁcit with hyperactivity disorder (ADHD)
symptoms decrease with age in contrast to OCD symptoms
that increase with age [17,18]. However, in our cohort adult
patients with coprophenomena reported ADHD more frequent-
ly and OCB/OCD less frequently compared to children with
coprophenomena (Table 3). It suggests that recall bias has been
unlikely to affect the results of our study signiﬁcantly.
Methodology of collecting data was different in children
and adults. Most clinical information regarding children are
provided by their parents whereas adults report themselves.Despite it, the ﬁndings in both groups were very similar
compared to the all GTS patients with regard to mean number
of mental disorders and behavioral problems. There was also no
difference between children and adults regarding the reporting
of mental disorders except ADHD, OCB/OCD and conduct
disorder (Table 3). In the latter, there were very small groups
of patients that limited to make the conclusions. Moreover, all
but one behavioral symptoms, sexually inappropriate behavior
that is probably troublesome for adults to admit, were reported
by children and adult patients in similar rate. In contrast to
comorbidity, tic severity did not differ between children and
adults (Table 3). However, tics rated as severe reached
borderline statistical signiﬁcance and were reported more often
by all GTS patients with coprophenomena compared to those
without coprolalia and copropraxia (Table 2). The number of
patients and descriptive way of tic severity may have affected
these ﬁndings. In conclusion, (1) the data regarding the
particular mental disorder and behavioral symptom occurring
in K+ and K groups should be interpreted with caution due to
small number of cases in most of these disorders and (2)
different methodology of collecting data in children and adults
may have inﬂuenced our results.
There is also possible referral bias because the patients
were evaluated by neurologist and the cases with more severe
psychopathology and behavioral problems (and probably high
proportion of coprophenomena) were referred to psychiatric
clinics. Most researchers found that only 8–12% of GTS patients
had no other psychopathology [22,23]. In our series, 25% of
patients did not have comorbid mental disorders (GTS
group). It might have been the reason for lower incidence of
copropraxia in Polish patients with GTS. The data regarding
the course of coprophenomena should be interpreted with
caution due to retrospective and one-time registration study
design. The assessment of natural course of coprophenomena
would require prospective study.
6. Conclusions
1. Coprophenomena appear only in minority of GTS patients,
typically around the time that tics are at their peak severity.
2. Coprolalia is nearly four times as common as copropraxia.
3. The course of coprophenomena may be unusual for tics in
some patients because of their persistence and invariability.
4. Coprophenomena are more frequent in patients with
comorbid mental disorders, behavioral problems and
severe tics.
5. Coprophenomena may reﬂect more widespread dysfunc-
tion of brain in those patients with GTS.
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